1. Home
  2. EMO vs EVO Comparison

EMO vs EVO Comparison

Compare EMO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearBridge Energy Midstream Opportunity Fund Inc.

EMO

ClearBridge Energy Midstream Opportunity Fund Inc.

HOLD

Current Price

$51.70

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.08

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMO
EVO
Founded
2011
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
934.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EMO
EVO
Price
$51.70
$3.08
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
50.5K
101.3K
Earning Date
01-01-0001
04-08-2026
Dividend Yield
6.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$41.54
$2.31
52 Week High
$54.90
$4.80

Technical Indicators

Market Signals
Indicator
EMO
EVO
Relative Strength Index (RSI) 61.49 55.87
Support Level $51.00 $2.87
Resistance Level $53.99 $3.78
Average True Range (ATR) 0.83 0.11
MACD 0.23 -0.00
Stochastic Oscillator 96.69 56.94

Price Performance

Historical Comparison
EMO
EVO

About EMO ClearBridge Energy Midstream Opportunity Fund Inc.

ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions. The Fund considers investments in midstream entities as those entities that provide midstream services including the gathering, transporting, processing, fractionation, storing, refining, and distribution of oil, natural gas liquids and natural gas.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: